IRAK2 c.814G>A ;(p.V272M)

Variant ID: 3-10258643-G-A

NM_001570.3(IRAK2):c.814G>A;(p.V272M)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.

Clinical Genitourinary Cancer
Bryce, Alan H AH; Borad, Mitesh J MJ; Egan, Jan B JB; Condjella, Rachel M RM; Liang, Winnie S WS; Fonseca, Rafael R; McCullough, Ann E AE; Hunt, Katherine S KS; Ritacca, Nicole R NR; Barrett, Michael T MT; Patel, Maitray D MD; Young, Scott W SW; Silva, Alvin C AC; Ho, Thai H TH; Halfdanarson, Thorvardur R TR; Stanton, Melissa L ML; Cheville, John J; Swanson, Scott S; Schneider, Daniel E DE; McWilliams, Robert R RR; Baker, Angela A; Aldrich, Jessica J; Kurdoglu, Ahmet A; Izatt, Tyler T; Christoforides, Alexis A; Cherni, Irene I; Nasser, Sara S; Reiman, Rebecca R; Cuyugan, Lori L; McDonald, Jacquelyn J; Adkins, Jonathan J; Mastrian, Stephen D SD; Von Hoff, Daniel D DD; Craig, David W DW; Stewart, A Keith AK; Carpten, John D JD
Publication Date: 2017-08

Variant appearance in text: IRAK2: V272M
PubMed Link: 28057415
Variant Present in the following documents:
  • NIHMS1622510-supplement-4.pdf
View BVdb publication page